LIVER CANCER 润色咨询

Liver Cancer

出版年份:暂无数据 年文章数:205 投稿命中率: 开通期刊会员,数据随心看

出版周期:Quarterly 自引率:暂无数据 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2192716, encodeId=1ccc2192e16f3, content=偏重的研究方向:肝癌<br>经验分享:为什么投稿10天了,从Pre-evaluation变成pending,然后不动了。。。pending是什么状态,,求大佬指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db718494675, createdName=张PD, createdTime=Tue Mar 12 10:24:51 CST 2024, time=2024-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2110186, encodeId=b67f211018699, content=偏重的研究方向:肝癌<br>经验分享:投稿一周了,一直处于Pre-evaluation,好希望被这个杂志接收啊,这个杂志感觉特别厉害!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92b78178644, createdName=ms8000000481530708, createdTime=Sat Jan 14 13:21:08 CST 2023, time=2023-01-14, status=1, ipAttribution=爱知县), GetPortalCommentsPageByObjectIdResponse(id=1243111, encodeId=33a4124311114, content=偏重的研究方向:肝癌<br>经验分享:投稿后通知我改格式 8月27重投后 status一直是resent 也不知道杂志社收到了没有。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Sun Sep 04 12:54:38 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898062, encodeId=41d38980626c, content=这杂志咋样啊,感觉偏冷门啊 投了好些天了,一直就with editor,哎,不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Mon Nov 09 20:39:14 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972354, encodeId=1ec79e23542b, content=投稿后第二天pre-evalued一周了,希望能送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Thu Jun 10 06:06:44 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110087, encodeId=9ca5211008e6e, content=有没有投稿成功被接收的呢?投了三天了,一直处于Pre-evaluation。这个杂志审稿周期大概是多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92b78178644, createdName=ms8000000481530708, createdTime=Fri Jan 13 16:27:20 CST 2023, time=2023-01-13, status=1, ipAttribution=爱知县), GetPortalCommentsPageByObjectIdResponse(id=1248227, encodeId=f911124822ef5, content=投稿一个多月没送审,发邮件询问了一下,隔天直接拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Fri Sep 09 22:46:56 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547160, encodeId=b78354e1600c, content=一审1.5月被拒.reviewers很专业.问题准确., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4ad1753686, createdName=Acts, createdTime=Thu Sep 14 00:00:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106787, encodeId=38691106e8710, content=期刊发送的信件里需要注意几个方面的内容?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106788, encodeId=6ad61106e88ea, content=什么是期刊编辑的意见和建议?什么是评审/审稿人/reviewer的意见和建议?两者有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2024-03-12 张PD 来自上海

    偏重的研究方向:肝癌
    经验分享:为什么投稿10天了,从Pre-evaluation变成pending,然后不动了。。。pending是什么状态,,求大佬指点

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2192716, encodeId=1ccc2192e16f3, content=偏重的研究方向:肝癌<br>经验分享:为什么投稿10天了,从Pre-evaluation变成pending,然后不动了。。。pending是什么状态,,求大佬指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db718494675, createdName=张PD, createdTime=Tue Mar 12 10:24:51 CST 2024, time=2024-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2110186, encodeId=b67f211018699, content=偏重的研究方向:肝癌<br>经验分享:投稿一周了,一直处于Pre-evaluation,好希望被这个杂志接收啊,这个杂志感觉特别厉害!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92b78178644, createdName=ms8000000481530708, createdTime=Sat Jan 14 13:21:08 CST 2023, time=2023-01-14, status=1, ipAttribution=爱知县), GetPortalCommentsPageByObjectIdResponse(id=1243111, encodeId=33a4124311114, content=偏重的研究方向:肝癌<br>经验分享:投稿后通知我改格式 8月27重投后 status一直是resent 也不知道杂志社收到了没有。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Sun Sep 04 12:54:38 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898062, encodeId=41d38980626c, content=这杂志咋样啊,感觉偏冷门啊 投了好些天了,一直就with editor,哎,不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Mon Nov 09 20:39:14 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972354, encodeId=1ec79e23542b, content=投稿后第二天pre-evalued一周了,希望能送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Thu Jun 10 06:06:44 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110087, encodeId=9ca5211008e6e, content=有没有投稿成功被接收的呢?投了三天了,一直处于Pre-evaluation。这个杂志审稿周期大概是多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92b78178644, createdName=ms8000000481530708, createdTime=Fri Jan 13 16:27:20 CST 2023, time=2023-01-13, status=1, ipAttribution=爱知县), GetPortalCommentsPageByObjectIdResponse(id=1248227, encodeId=f911124822ef5, content=投稿一个多月没送审,发邮件询问了一下,隔天直接拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Fri Sep 09 22:46:56 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547160, encodeId=b78354e1600c, content=一审1.5月被拒.reviewers很专业.问题准确., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4ad1753686, createdName=Acts, createdTime=Thu Sep 14 00:00:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106787, encodeId=38691106e8710, content=期刊发送的信件里需要注意几个方面的内容?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106788, encodeId=6ad61106e88ea, content=什么是期刊编辑的意见和建议?什么是评审/审稿人/reviewer的意见和建议?两者有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2023-01-14 ms8000000481530708 来自爱知县

    偏重的研究方向:肝癌
    经验分享:投稿一周了,一直处于Pre-evaluation,好希望被这个杂志接收啊,这个杂志感觉特别厉害!

    2

    展开2条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2192716, encodeId=1ccc2192e16f3, content=偏重的研究方向:肝癌<br>经验分享:为什么投稿10天了,从Pre-evaluation变成pending,然后不动了。。。pending是什么状态,,求大佬指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db718494675, createdName=张PD, createdTime=Tue Mar 12 10:24:51 CST 2024, time=2024-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2110186, encodeId=b67f211018699, content=偏重的研究方向:肝癌<br>经验分享:投稿一周了,一直处于Pre-evaluation,好希望被这个杂志接收啊,这个杂志感觉特别厉害!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92b78178644, createdName=ms8000000481530708, createdTime=Sat Jan 14 13:21:08 CST 2023, time=2023-01-14, status=1, ipAttribution=爱知县), GetPortalCommentsPageByObjectIdResponse(id=1243111, encodeId=33a4124311114, content=偏重的研究方向:肝癌<br>经验分享:投稿后通知我改格式 8月27重投后 status一直是resent 也不知道杂志社收到了没有。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Sun Sep 04 12:54:38 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898062, encodeId=41d38980626c, content=这杂志咋样啊,感觉偏冷门啊 投了好些天了,一直就with editor,哎,不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Mon Nov 09 20:39:14 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972354, encodeId=1ec79e23542b, content=投稿后第二天pre-evalued一周了,希望能送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Thu Jun 10 06:06:44 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110087, encodeId=9ca5211008e6e, content=有没有投稿成功被接收的呢?投了三天了,一直处于Pre-evaluation。这个杂志审稿周期大概是多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92b78178644, createdName=ms8000000481530708, createdTime=Fri Jan 13 16:27:20 CST 2023, time=2023-01-13, status=1, ipAttribution=爱知县), GetPortalCommentsPageByObjectIdResponse(id=1248227, encodeId=f911124822ef5, content=投稿一个多月没送审,发邮件询问了一下,隔天直接拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Fri Sep 09 22:46:56 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547160, encodeId=b78354e1600c, content=一审1.5月被拒.reviewers很专业.问题准确., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4ad1753686, createdName=Acts, createdTime=Thu Sep 14 00:00:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106787, encodeId=38691106e8710, content=期刊发送的信件里需要注意几个方面的内容?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106788, encodeId=6ad61106e88ea, content=什么是期刊编辑的意见和建议?什么是评审/审稿人/reviewer的意见和建议?两者有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2022-09-04 ms3000000209605964

    偏重的研究方向:肝癌
    经验分享:投稿后通知我改格式 8月27重投后 status一直是resent 也不知道杂志社收到了没有。

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2192716, encodeId=1ccc2192e16f3, content=偏重的研究方向:肝癌<br>经验分享:为什么投稿10天了,从Pre-evaluation变成pending,然后不动了。。。pending是什么状态,,求大佬指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db718494675, createdName=张PD, createdTime=Tue Mar 12 10:24:51 CST 2024, time=2024-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2110186, encodeId=b67f211018699, content=偏重的研究方向:肝癌<br>经验分享:投稿一周了,一直处于Pre-evaluation,好希望被这个杂志接收啊,这个杂志感觉特别厉害!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92b78178644, createdName=ms8000000481530708, createdTime=Sat Jan 14 13:21:08 CST 2023, time=2023-01-14, status=1, ipAttribution=爱知县), GetPortalCommentsPageByObjectIdResponse(id=1243111, encodeId=33a4124311114, content=偏重的研究方向:肝癌<br>经验分享:投稿后通知我改格式 8月27重投后 status一直是resent 也不知道杂志社收到了没有。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Sun Sep 04 12:54:38 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898062, encodeId=41d38980626c, content=这杂志咋样啊,感觉偏冷门啊 投了好些天了,一直就with editor,哎,不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Mon Nov 09 20:39:14 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972354, encodeId=1ec79e23542b, content=投稿后第二天pre-evalued一周了,希望能送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Thu Jun 10 06:06:44 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110087, encodeId=9ca5211008e6e, content=有没有投稿成功被接收的呢?投了三天了,一直处于Pre-evaluation。这个杂志审稿周期大概是多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92b78178644, createdName=ms8000000481530708, createdTime=Fri Jan 13 16:27:20 CST 2023, time=2023-01-13, status=1, ipAttribution=爱知县), GetPortalCommentsPageByObjectIdResponse(id=1248227, encodeId=f911124822ef5, content=投稿一个多月没送审,发邮件询问了一下,隔天直接拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Fri Sep 09 22:46:56 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547160, encodeId=b78354e1600c, content=一审1.5月被拒.reviewers很专业.问题准确., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4ad1753686, createdName=Acts, createdTime=Thu Sep 14 00:00:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106787, encodeId=38691106e8710, content=期刊发送的信件里需要注意几个方面的内容?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106788, encodeId=6ad61106e88ea, content=什么是期刊编辑的意见和建议?什么是评审/审稿人/reviewer的意见和建议?两者有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2020-11-09 darktempler

    这杂志咋样啊,感觉偏冷门啊 投了好些天了,一直就with editor,哎,不知道啥意思

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2192716, encodeId=1ccc2192e16f3, content=偏重的研究方向:肝癌<br>经验分享:为什么投稿10天了,从Pre-evaluation变成pending,然后不动了。。。pending是什么状态,,求大佬指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db718494675, createdName=张PD, createdTime=Tue Mar 12 10:24:51 CST 2024, time=2024-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2110186, encodeId=b67f211018699, content=偏重的研究方向:肝癌<br>经验分享:投稿一周了,一直处于Pre-evaluation,好希望被这个杂志接收啊,这个杂志感觉特别厉害!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92b78178644, createdName=ms8000000481530708, createdTime=Sat Jan 14 13:21:08 CST 2023, time=2023-01-14, status=1, ipAttribution=爱知县), GetPortalCommentsPageByObjectIdResponse(id=1243111, encodeId=33a4124311114, content=偏重的研究方向:肝癌<br>经验分享:投稿后通知我改格式 8月27重投后 status一直是resent 也不知道杂志社收到了没有。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Sun Sep 04 12:54:38 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898062, encodeId=41d38980626c, content=这杂志咋样啊,感觉偏冷门啊 投了好些天了,一直就with editor,哎,不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Mon Nov 09 20:39:14 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972354, encodeId=1ec79e23542b, content=投稿后第二天pre-evalued一周了,希望能送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Thu Jun 10 06:06:44 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110087, encodeId=9ca5211008e6e, content=有没有投稿成功被接收的呢?投了三天了,一直处于Pre-evaluation。这个杂志审稿周期大概是多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92b78178644, createdName=ms8000000481530708, createdTime=Fri Jan 13 16:27:20 CST 2023, time=2023-01-13, status=1, ipAttribution=爱知县), GetPortalCommentsPageByObjectIdResponse(id=1248227, encodeId=f911124822ef5, content=投稿一个多月没送审,发邮件询问了一下,隔天直接拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Fri Sep 09 22:46:56 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547160, encodeId=b78354e1600c, content=一审1.5月被拒.reviewers很专业.问题准确., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4ad1753686, createdName=Acts, createdTime=Thu Sep 14 00:00:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106787, encodeId=38691106e8710, content=期刊发送的信件里需要注意几个方面的内容?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106788, encodeId=6ad61106e88ea, content=什么是期刊编辑的意见和建议?什么是评审/审稿人/reviewer的意见和建议?两者有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2021-06-10 1dd96cb3m86(暂无匿称)

    投稿后第二天pre-evalued一周了,希望能送外审

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2192716, encodeId=1ccc2192e16f3, content=偏重的研究方向:肝癌<br>经验分享:为什么投稿10天了,从Pre-evaluation变成pending,然后不动了。。。pending是什么状态,,求大佬指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db718494675, createdName=张PD, createdTime=Tue Mar 12 10:24:51 CST 2024, time=2024-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2110186, encodeId=b67f211018699, content=偏重的研究方向:肝癌<br>经验分享:投稿一周了,一直处于Pre-evaluation,好希望被这个杂志接收啊,这个杂志感觉特别厉害!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92b78178644, createdName=ms8000000481530708, createdTime=Sat Jan 14 13:21:08 CST 2023, time=2023-01-14, status=1, ipAttribution=爱知县), GetPortalCommentsPageByObjectIdResponse(id=1243111, encodeId=33a4124311114, content=偏重的研究方向:肝癌<br>经验分享:投稿后通知我改格式 8月27重投后 status一直是resent 也不知道杂志社收到了没有。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Sun Sep 04 12:54:38 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898062, encodeId=41d38980626c, content=这杂志咋样啊,感觉偏冷门啊 投了好些天了,一直就with editor,哎,不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Mon Nov 09 20:39:14 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972354, encodeId=1ec79e23542b, content=投稿后第二天pre-evalued一周了,希望能送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Thu Jun 10 06:06:44 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110087, encodeId=9ca5211008e6e, content=有没有投稿成功被接收的呢?投了三天了,一直处于Pre-evaluation。这个杂志审稿周期大概是多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92b78178644, createdName=ms8000000481530708, createdTime=Fri Jan 13 16:27:20 CST 2023, time=2023-01-13, status=1, ipAttribution=爱知县), GetPortalCommentsPageByObjectIdResponse(id=1248227, encodeId=f911124822ef5, content=投稿一个多月没送审,发邮件询问了一下,隔天直接拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Fri Sep 09 22:46:56 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547160, encodeId=b78354e1600c, content=一审1.5月被拒.reviewers很专业.问题准确., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4ad1753686, createdName=Acts, createdTime=Thu Sep 14 00:00:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106787, encodeId=38691106e8710, content=期刊发送的信件里需要注意几个方面的内容?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106788, encodeId=6ad61106e88ea, content=什么是期刊编辑的意见和建议?什么是评审/审稿人/reviewer的意见和建议?两者有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2023-01-13 ms8000000481530708 来自爱知县

    有没有投稿成功被接收的呢?投了三天了,一直处于Pre-evaluation。这个杂志审稿周期大概是多久啊

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2192716, encodeId=1ccc2192e16f3, content=偏重的研究方向:肝癌<br>经验分享:为什么投稿10天了,从Pre-evaluation变成pending,然后不动了。。。pending是什么状态,,求大佬指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db718494675, createdName=张PD, createdTime=Tue Mar 12 10:24:51 CST 2024, time=2024-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2110186, encodeId=b67f211018699, content=偏重的研究方向:肝癌<br>经验分享:投稿一周了,一直处于Pre-evaluation,好希望被这个杂志接收啊,这个杂志感觉特别厉害!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92b78178644, createdName=ms8000000481530708, createdTime=Sat Jan 14 13:21:08 CST 2023, time=2023-01-14, status=1, ipAttribution=爱知县), GetPortalCommentsPageByObjectIdResponse(id=1243111, encodeId=33a4124311114, content=偏重的研究方向:肝癌<br>经验分享:投稿后通知我改格式 8月27重投后 status一直是resent 也不知道杂志社收到了没有。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Sun Sep 04 12:54:38 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898062, encodeId=41d38980626c, content=这杂志咋样啊,感觉偏冷门啊 投了好些天了,一直就with editor,哎,不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Mon Nov 09 20:39:14 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972354, encodeId=1ec79e23542b, content=投稿后第二天pre-evalued一周了,希望能送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Thu Jun 10 06:06:44 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110087, encodeId=9ca5211008e6e, content=有没有投稿成功被接收的呢?投了三天了,一直处于Pre-evaluation。这个杂志审稿周期大概是多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92b78178644, createdName=ms8000000481530708, createdTime=Fri Jan 13 16:27:20 CST 2023, time=2023-01-13, status=1, ipAttribution=爱知县), GetPortalCommentsPageByObjectIdResponse(id=1248227, encodeId=f911124822ef5, content=投稿一个多月没送审,发邮件询问了一下,隔天直接拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Fri Sep 09 22:46:56 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547160, encodeId=b78354e1600c, content=一审1.5月被拒.reviewers很专业.问题准确., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4ad1753686, createdName=Acts, createdTime=Thu Sep 14 00:00:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106787, encodeId=38691106e8710, content=期刊发送的信件里需要注意几个方面的内容?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106788, encodeId=6ad61106e88ea, content=什么是期刊编辑的意见和建议?什么是评审/审稿人/reviewer的意见和建议?两者有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2022-09-09 YJJJJJ

    投稿一个多月没送审,发邮件询问了一下,隔天直接拒稿。

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2192716, encodeId=1ccc2192e16f3, content=偏重的研究方向:肝癌<br>经验分享:为什么投稿10天了,从Pre-evaluation变成pending,然后不动了。。。pending是什么状态,,求大佬指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db718494675, createdName=张PD, createdTime=Tue Mar 12 10:24:51 CST 2024, time=2024-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2110186, encodeId=b67f211018699, content=偏重的研究方向:肝癌<br>经验分享:投稿一周了,一直处于Pre-evaluation,好希望被这个杂志接收啊,这个杂志感觉特别厉害!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92b78178644, createdName=ms8000000481530708, createdTime=Sat Jan 14 13:21:08 CST 2023, time=2023-01-14, status=1, ipAttribution=爱知县), GetPortalCommentsPageByObjectIdResponse(id=1243111, encodeId=33a4124311114, content=偏重的研究方向:肝癌<br>经验分享:投稿后通知我改格式 8月27重投后 status一直是resent 也不知道杂志社收到了没有。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Sun Sep 04 12:54:38 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898062, encodeId=41d38980626c, content=这杂志咋样啊,感觉偏冷门啊 投了好些天了,一直就with editor,哎,不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Mon Nov 09 20:39:14 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972354, encodeId=1ec79e23542b, content=投稿后第二天pre-evalued一周了,希望能送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Thu Jun 10 06:06:44 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110087, encodeId=9ca5211008e6e, content=有没有投稿成功被接收的呢?投了三天了,一直处于Pre-evaluation。这个杂志审稿周期大概是多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92b78178644, createdName=ms8000000481530708, createdTime=Fri Jan 13 16:27:20 CST 2023, time=2023-01-13, status=1, ipAttribution=爱知县), GetPortalCommentsPageByObjectIdResponse(id=1248227, encodeId=f911124822ef5, content=投稿一个多月没送审,发邮件询问了一下,隔天直接拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Fri Sep 09 22:46:56 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547160, encodeId=b78354e1600c, content=一审1.5月被拒.reviewers很专业.问题准确., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4ad1753686, createdName=Acts, createdTime=Thu Sep 14 00:00:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106787, encodeId=38691106e8710, content=期刊发送的信件里需要注意几个方面的内容?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106788, encodeId=6ad61106e88ea, content=什么是期刊编辑的意见和建议?什么是评审/审稿人/reviewer的意见和建议?两者有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2017-09-14 Acts

    一审1.5月被拒.reviewers很专业.问题准确.

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2192716, encodeId=1ccc2192e16f3, content=偏重的研究方向:肝癌<br>经验分享:为什么投稿10天了,从Pre-evaluation变成pending,然后不动了。。。pending是什么状态,,求大佬指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db718494675, createdName=张PD, createdTime=Tue Mar 12 10:24:51 CST 2024, time=2024-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2110186, encodeId=b67f211018699, content=偏重的研究方向:肝癌<br>经验分享:投稿一周了,一直处于Pre-evaluation,好希望被这个杂志接收啊,这个杂志感觉特别厉害!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92b78178644, createdName=ms8000000481530708, createdTime=Sat Jan 14 13:21:08 CST 2023, time=2023-01-14, status=1, ipAttribution=爱知县), GetPortalCommentsPageByObjectIdResponse(id=1243111, encodeId=33a4124311114, content=偏重的研究方向:肝癌<br>经验分享:投稿后通知我改格式 8月27重投后 status一直是resent 也不知道杂志社收到了没有。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Sun Sep 04 12:54:38 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898062, encodeId=41d38980626c, content=这杂志咋样啊,感觉偏冷门啊 投了好些天了,一直就with editor,哎,不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Mon Nov 09 20:39:14 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972354, encodeId=1ec79e23542b, content=投稿后第二天pre-evalued一周了,希望能送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Thu Jun 10 06:06:44 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110087, encodeId=9ca5211008e6e, content=有没有投稿成功被接收的呢?投了三天了,一直处于Pre-evaluation。这个杂志审稿周期大概是多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92b78178644, createdName=ms8000000481530708, createdTime=Fri Jan 13 16:27:20 CST 2023, time=2023-01-13, status=1, ipAttribution=爱知县), GetPortalCommentsPageByObjectIdResponse(id=1248227, encodeId=f911124822ef5, content=投稿一个多月没送审,发邮件询问了一下,隔天直接拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Fri Sep 09 22:46:56 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547160, encodeId=b78354e1600c, content=一审1.5月被拒.reviewers很专业.问题准确., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4ad1753686, createdName=Acts, createdTime=Thu Sep 14 00:00:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106787, encodeId=38691106e8710, content=期刊发送的信件里需要注意几个方面的内容?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106788, encodeId=6ad61106e88ea, content=什么是期刊编辑的意见和建议?什么是评审/审稿人/reviewer的意见和建议?两者有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2021-12-28 MS54455111222

    期刊发送的信件里需要注意几个方面的内容?

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2192716, encodeId=1ccc2192e16f3, content=偏重的研究方向:肝癌<br>经验分享:为什么投稿10天了,从Pre-evaluation变成pending,然后不动了。。。pending是什么状态,,求大佬指点, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=8, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=db718494675, createdName=张PD, createdTime=Tue Mar 12 10:24:51 CST 2024, time=2024-03-12, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2110186, encodeId=b67f211018699, content=偏重的研究方向:肝癌<br>经验分享:投稿一周了,一直处于Pre-evaluation,好希望被这个杂志接收啊,这个杂志感觉特别厉害!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92b78178644, createdName=ms8000000481530708, createdTime=Sat Jan 14 13:21:08 CST 2023, time=2023-01-14, status=1, ipAttribution=爱知县), GetPortalCommentsPageByObjectIdResponse(id=1243111, encodeId=33a4124311114, content=偏重的研究方向:肝癌<br>经验分享:投稿后通知我改格式 8月27重投后 status一直是resent 也不知道杂志社收到了没有。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=257f6155439, createdName=ms3000000209605964, createdTime=Sun Sep 04 12:54:38 CST 2022, time=2022-09-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898062, encodeId=41d38980626c, content=这杂志咋样啊,感觉偏冷门啊 投了好些天了,一直就with editor,哎,不知道啥意思, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Mon Nov 09 20:39:14 CST 2020, time=2020-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=972354, encodeId=1ec79e23542b, content=投稿后第二天pre-evalued一周了,希望能送外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/24/60770a300e3f99e9c54e85067da5d704.jpg, createdBy=45db1636816, createdName=1dd96cb3m86(暂无匿称), createdTime=Thu Jun 10 06:06:44 CST 2021, time=2021-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110087, encodeId=9ca5211008e6e, content=有没有投稿成功被接收的呢?投了三天了,一直处于Pre-evaluation。这个杂志审稿周期大概是多久啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92b78178644, createdName=ms8000000481530708, createdTime=Fri Jan 13 16:27:20 CST 2023, time=2023-01-13, status=1, ipAttribution=爱知县), GetPortalCommentsPageByObjectIdResponse(id=1248227, encodeId=f911124822ef5, content=投稿一个多月没送审,发邮件询问了一下,隔天直接拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=d21b5560214, createdName=YJJJJJ, createdTime=Fri Sep 09 22:46:56 CST 2022, time=2022-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547160, encodeId=b78354e1600c, content=一审1.5月被拒.reviewers很专业.问题准确., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=251, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d4ad1753686, createdName=Acts, createdTime=Thu Sep 14 00:00:00 CST 2017, time=2017-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106787, encodeId=38691106e8710, content=期刊发送的信件里需要注意几个方面的内容?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1106788, encodeId=6ad61106e88ea, content=什么是期刊编辑的意见和建议?什么是评审/审稿人/reviewer的意见和建议?两者有什么不同?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=56, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Tue Dec 28 14:52:53 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2021-12-28 乌云背后的幸福线

    什么是期刊编辑的意见和建议?什么是评审/审稿人/reviewer的意见和建议?两者有什么不同?

    1

    展开1条回复
共29条页码: 1/3页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分